BASF SE (BASFn.DE)

BASFn.DE on Xetra

87.90EUR
22 May 2015
Change (% chg)

€-0.08 (-0.09%)
Prev Close
€87.98
Open
€88.40
Day's High
€88.42
Day's Low
€87.71
Volume
1,700,747
Avg. Vol
3,234,948
52-wk High
€97.22
52-wk Low
€64.27

BASFn.DE

Chart for BASFn.DE

About

BASF SE is a Germany-based chemical company. It diversifies its activities into five business segments: Chemicals, providing basic products and specialties including nitric acid and methanol, among others; Performance Products, providing products for the coatings and paints industry, cosmetics, detergents, products for the paper... (more)

Overall

Beta: 1.25
Market Cap(Mil.): €80,807.76
Shares Outstanding(Mil.): 918.48
Dividend: 2.80
Yield (%): 3.18

Financials

  BASFn.DE Industry Sector
P/E (TTM): 16.65 11.19 18.48
EPS (TTM): 5.28 -- --
ROI: 9.33 4.83 8.12
ROE: 17.07 5.89 11.08
Search Stocks

Monsanto's Syngenta gambit hinges on sale of seed businesses: sources

LONDON/FRANKFURT - U.S. seeds giant Monsanto is trying to line up buyers for assets worth up to $8 billion to appease competition authorities before making a fresh takeover approach for Swiss Syngenta, possibly within three weeks, industry sources said.

14 May 2015

RPT-Monsanto and Syngenta hire U.S. banks to advise on possible takeover -sources

* BASF and Dow Chemical among other potential suitors -source

08 May 2015

Monsanto and Syngenta hire U.S. banks to advise on possible takeover -sources

* BASF and Dow Chemical among other potential suitors -source

07 May 2015

Siegfried buys BASF drug ingredient businesses for $306 million

FRANKFURT - German chemicals group BASF has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding for 270 million euros ($306 million), including assumed debt.

07 May 2015

Siegfried buys BASF drug ingredient businesses for 270 mln eur

FRANKFURT, May 7 - German chemicals group BASF has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding for 270 million euros ($306 million), including assumed debt.

07 May 2015

BRIEF-Siegfried Holding buys segments of BASF's pharmaceutical supply business

* Acquires significant segments of BASF's pharmaceutical supply business

07 May 2015

UPDATE 2-BASF says low oil price to stymie earnings growth

* Confirms forecast for flat 2015 operating profit (Adds revenue growth, analyst comment, share price)

30 Apr 2015

BASF sues Umicore in United States for patent infringements

FRANKFURT/BRUSSELS - German chemicals firm BASF said on Thursday it has sued Belgian specialty materials group Umicore in the United States for infringing two patents related to components for lithium-ion batteries.

02 Apr 2015

BASF sues Umicore in United States for patent infringements

FRANKFURT/BRUSSELS, April 2 - German chemicals firm BASF said on Thursday it has sued Belgian specialty materials group Umicore in the United States for infringing two patents related to components for lithium-ion batteries.

02 Apr 2015

BRIEF-BASF to grant sublicenses of ExxonMobil gas treatment technology

* Says to grant sublicenses of ExxonMobil gas treatment technology Further company coverage:

18 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Validea
$12.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Wright Reports
$169.00
Provider: Wright Reports
$169.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks